|
Delayed
OTC Markets
09:35:30 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 0.0530 USD | -24.29% |
|
+32.17% | +41.33% |
| 08-10 | Agentix Corp. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 07-01 | Agentix Corp. Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.12M | - | - | - | - | - |
| 64.14B | |||||
| 55.53B | |||||
| 53.03B | |||||
| 45.99B | |||||
| 42.45B |
- Stock Market
- Stocks
- AGTX Stock
- Charts Agentix Corp.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
